Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Yeast Company, Lallemand, Expands Montreal R&D Facility With Eye to Genomics

NEW YORK, Aug. 13 (GenomeWeb News) –  Lallemand, a privately held Canadian company specializing in lactic acid bacteria and yeast, has announced that it is expanding its research facilities at Montreal’s Biotechnology Research Institute of the National Research Council of Canada.

The enlarged R&D team, led by Thomas Tompkins, will focus on biochemical and microbiological characterization of probiotic strains, their metabolic products, and mineral-enriched yeast.

The company said that its expanded research facilities would allow it to utilize genomic and proteomic technologies.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.